AMCP applauds the 10th Circuit for protecting the vital functions of ERISA & Medicare Part D, which provide essential services to workers and seniors, in yesterday’s ruling in the case of @PCMA v. Glen Mulready.

The AMCP Format public comment period facilitates an exchange of information between manufacturers and health care decision-makers to inform formulary and coverage decisions.

AMCP issued the following statement regarding the Supreme Court’s April 21 order.

AMCP welcomes the introduction of the Medicaid VBPs for Patients Act. The legislation would expand Medicaid access to novel therapies.

AMCP released the following statement in response to conflicting federal court rulings regarding Food & Drug Administration drug approval.

The AMCP Foundation has posthumously awarded the 2023 Steven G. Avey Award to Judith A. Cahill, former CEO of AMCP, for her sustained and exemplary service to the practice of pharmacy. Cahill's legacy includes creating the Pharmacy Quality Alliance, the AMCP Format for Formulary Submissions, and championing the passing of the Medicare Modernization Act and the Affordable Care Act. The award was accepted by AMCP past president Marissa Schlaifer, AMCP Foundation president Annesha White, and Cahill's niece Kathy Kurek at AMCP 2023.

The AMCP Foundation and its partners have announced the winners of the 23rd Annual National Student Pharmacist Pharmacy & Therapeutics Competition, where teams from across the country developed a drug monograph and recommendations for formulary placement. The University of Connecticut School of Pharmacy took first place, followed by the University of Washington School of Pharmacy and the University of Minnesota College of Pharmacy.